Farnesyl transferase inhibiting 1,2-annelated quinoline enantiomer
(−)-5-(3-Chlorophenyl)-α-(4-chlorophenyl)-α-(1-methyl-1H-imidazol-5-yl)tetrazolo-[1,5-a]quinazoline-7-methanamine and its pharmaceutically acceptable acid addition salts, and the use of such compounds in medicine especially for the treatment of cancer.
Saved in:
Main Authors | , , |
---|---|
Format | Patent |
Language | English |
Published |
27.11.2012
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | (−)-5-(3-Chlorophenyl)-α-(4-chlorophenyl)-α-(1-methyl-1H-imidazol-5-yl)tetrazolo-[1,5-a]quinazoline-7-methanamine and its pharmaceutically acceptable acid addition salts, and the use of such compounds in medicine especially for the treatment of cancer. |
---|---|
Bibliography: | Application Number: US20070926741 |